chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VACCINE GIVEN 6 HOURS AFTER THE FIRST PUNCTURE OF THE VIAL; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 01-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2021, the subject experienced vaccine given 6 hours after the first puncture of the vial. On 01-JUL-2021, the subject experienced incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the incorrect product storage and vaccine given 6 hours after the first puncture of the vial was not reported. This report was non-serious.
herpes; This case was reported by a consumer via call center representative and described the occurrence of herpes virus infection in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced herpes virus infection. On an unknown date, the outcome of the herpes virus infection was unknown.   It was unknown if the reporter considered the herpes virus infection to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had a vaccine 6 weeks ago from the time of reporting and developed herpes last week from the time of reporting. The patient want to know if having an outbreak had anything to do with the vaccine. The patient asked had anyone reported such event. The physician replied that it can lay dormant in the body for years. The patient want to know if the vaccine had anything to do with the outbreak.
Immediate pain at injection site, soreness shoulder (left) with first shot.  Also reported tingling in both hands.  That was improved by the next day.  WIth second shot numbness, tingling both hands.   occurred within hours of injection.  Then developed pain pain in both shoulders, That pain gone by next day but reported diffuse myalgias 2 days later.  Persistence of tingling in hands and also noted tingling in L foot and twitching L hand and foot,  band-like sensation L forearm.  Used tylenol for pain,  There were no other symptoms, no rash was noted.  Seen 5/3/21- was feeling generally weak, had baseline complex regional pain synd sx R leg.  Ongoing tingling L.  Examination was unremarkable-no focal weakness, neuro deficits, intact touch except hypesthesia R foot/ankle Referred to neurology.  Laboratory for inflammatory/rhematologic disease negative.  She decline EMG/NCV.  Gradual improvement with intermittent tingling L-worse with use.  Mostly better until September 2021 when she had a surgical procedure on forearm (melanoma resection).   That caused a flare of pain/tingling and weakness which is now improving.
vaccine was frozen rather than refrigerated, dose was given and no adverse reaction was reported, offered to revaccinate.
I started to have symptoms on April 02. I was really tired with a headache. I had a worse cough than usual, a sore throat and a fever. I was exhausted. I contacted my doctor on the 3rd and she arranged to meet me at the office on the 4th and she did a swab test. On the 5th she advised me that I was positive and she arranged for an infusion of monoclonal antibodies which I got on the 6th at the hospital. I continued to be fairly sick through the rest of that week and the next. I started to feel better about the 18th or 19th. I feel completed recovered outside of the feeling of being tired. I am still needing to take a nap at a moments notice.
Immediately after getting vaccinated at 2:40, I felt my tongue was weird like shell all around my tongue. They gave me fruit juice and a chip bag. I stayed until 3:10. My tongue was not responding to the sweetness of the fruit and not much salt from the chips. I still tasted the fruit juice and chips even after an hour after injection. At 9PM at night I checked my tongue and it was paler and somewhat swollen with indication marks on the side of my tongue. I had a rash under both shoulder blades that was like hives and redness, more on my left shoulder blade than the right shoulder blade that was itchy. I was still less sensitive to taste. The second day, I started to have a fever with cough. I ate pickles and my I could not taste them. I also got a headache and became short of breath while in shower. I started to develop a low grade fever and became sore all over. The hives had then moved and spread to the back of my neck. Then my fever got stronger later on at 11PM. I checked my oxygen level which was 98 and my pulse was normal. I also had a slight sore throat. On the third day, my temperature went back to normal range but was sweaty all throughout the day. I was still fatigued, I had restless sleep. On my fourth day, I started to feel some better.  Then on 12/30/2021, around 8:30PM I developed a headache and stomach ache. I also got diarrhea and some nausea. The second day, I had dry throat with a cough. I thought it could be a stomach flu. I developed a fever at 2:10PM and I had a cough but did not lose smell or taste. I went to get a COVID-19 test 1/3/2022 which was positive. The fever was gone within 4 days but the cough lingered for a 3 weeks. Some days I lost some taste or smell but not completely. I had stuffy nose for a few days. I had a very bad sore throat that lasted about 10 days.
received the Moderna COVID-19 Vaccine and booster; cold feet 2 or 3 weeks ago which comes and goes; started taking for circulation/also mentioned about a gas leak in his home which may cause issues in circulation according to his research; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team, Program ID: The reporter is the patient.  A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing), notes: Caller's thyroid also looked good. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine Moderna (Primary Immunization series complete but unknown manufacturer.), for COVID-19 Immunization; Covid-19 vaccine Moderna (Dose number unknown booster), for COVID-19 Immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown", described as "received the Moderna COVID-19 Vaccine and booster"; PERIPHERAL COLDNESS (non-serious), outcome "unknown", described as "cold feet 2 or 3 weeks ago which comes and goes"; POOR PERIPHERAL CIRCULATION (non-serious), outcome "unknown", described as "started taking for circulation/also mentioned about a gas leak in his home which may cause issues in circulation according to his research". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: 48-year-old male patient called stating that he received the Moderna COVID-19 Vaccine and booster 8 and a half months ago. Patient received the Pfizer COVID-19 Vaccine a month and a half ago. Caller started having cold feet 2 or 3 weeks ago which comes and goes. taking for circulation, garlic, and fish oil, had his lab and blood work return as normal, thyroid also looked good and also mentioned about a gas leak in his home which may cause issues in circulation according to his research.  The information on the batch/lot number for (BNT162B2, BNT162B2 OMI BA.4-5), has been requested and will be submitted if and when received.
Received immunization (Fluzone) 2NOV04. Woke upon 3NOV04 with maculopapular rash on trunk that over course of next days progressed and spread to extremities. No pruritus , no other symptoms, no fever, no URI symptoms.
2JAN98 had a low fever-warm to touch;no temp taken;broke out in pox 17 altogether;all scabbed over by 8JAN98;confirmed by MD;no known exposure;
On 4/9/2021 five minutes after receiving second Moderna COVID vaccine patient became dizzy and had shortness of breath along with chest pain. EMS was called to the location and the patient was transported to the ER. There she felt jittery and lightheaded. Symptoms did resolve and the patient was discharge from the ER approximately 3 hours after arrival.
1 day after receiving Hepatitis A vaccine in left arm - pt developed redness & swelling at site. On 9/2 - pt seen by doctor in office - Recommended ice to arm & BENADRYL 25mg BID.
ANXIETY (EXTREME SHORTNESS OF BREATH); This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no history of anxiety or of shortness of breath. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced anxiety (extreme shortness of breath). Treatment medications (dates unspecified) included: prednisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anxiety (extreme shortness of breath). This report was non-serious.
Subconjunctival Hemorrhage in left eye. No pain or swelling. dissipating within the week.
On 1/11/01, had well child visit. On 1/16/01, to ER with temperature of 103F with febrile convulsion. Dx'd with viral infection. On 1/17/01 follow-up, fever was down to 99.9F. Throat infected. Mom has history of febrile seizures as a child.
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by reporter. No treatment details were provided by reporter.
Fever 102 f; Extreme chill; Pain in joints and bones; Pain in joints and bones; Headache; Swollen, itchy, painful arm and armpit; Swollen, itchy, painful arm and armpit; painful arm and armpit; Dose Number: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 23Nov2021 10:45 (Batch/Lot number: unknown) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included Allergic Asthma (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included Bnt162b2 (Dose Number: 2, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, prev dose product=COVID 19,, prev dose brand=Pfizer), administration date: 22Mar2021, when the patient was 47 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Location of injection: Arm Left, Vaccine Administration Time: 10:45 AM, prev dose product=COVID 19,, prev dose brand=Pfizer), administration date: 01Mar2021, when the patient was 47 years old, for COVID-19 Immunization. The following information was reported IMMUNISATION (non-serious) with onset 23Nov2021 10:45, outcome unknown; PYREXIA (non-serious) with onset 23Nov2021 16:00, outcome not recovered; CHILLS (non-serious) with onset 23Nov2021 16:00, outcome recovering; ARTHRALGIA (non-serious), BONE PAIN (non-serious) all with onset 23Nov2021 16:00, outcome not recovered; HEADACHE (non-serious) with onset 23Nov2021 16:00, outcome not recovered; PERIPHERAL SWELLING (non-serious), PRURITUS (non-serious) all with onset 23Nov2021 16:00, outcome recovering; PAIN IN EXTREMITY (non-serious) with onset 23Nov2021 16:00, outcome not recovered. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia, arthralgia, bone pain, headache, and pain in extremity. Therapeutic measures were not taken as a result of chills, peripheral swelling, and pruritus.  On 23Nov2021 the patient's fever was 102F.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Mom reported infant would not lay down for a nap would not eat was having muscle spasm. Called MD told to go to ER. Mother states child would not walk or talk.
Headache - feeling of slight pain in right side of head, like "just sitting there waiting for something to trigger it", it is ever present. Every 2-3 weeks a full onset headache will occur causing severe throbbing pain in right side of head, starts behind right eye, eyes become read and waters severely, becomes light sensitive, begins to creep along right side of hear to the back of head, feeling like my hair hurts, usually lasts 2-3 hours, only has occurred only in a day, will begin to subside but will come "roaring" back, usually incapable of doing anything during the event. In addition, have tingling and numbness in left arm.
Information has been received from a 67 year old female with no allergies or pertinent medical history who on 20-AUG-2007 was vaccinated with a single dose of Zostavax (Oka/Merck). On 20-AUG-2007 the patient developed injection site pain which expanded throughout her body. The patient "can't walk." The patient described herself as "symptomatic of having shingles". Unspecified medical attention was sought. Unspecified "blood work" was performed. No results were reported. At the time of this report the patient had not recovered. No further information was provided. There was no product quality complaint involved. Additional information is not expected.
Redness initially around the site with swelling. Redness spread making the rash bigger and hot to the touch. Swelling increased make the site raised. This occurred over a 12 hour period and woke on August 27, 2016 to the rash being larger, measuring 10cmx8cm. Took to the doctor and they provided prescription for Augmentin. The doctor drew around the rash so I could watch for more movement, which did occurred by another cm around. Augmentin was started at dinner time and will continue for 10 days.
Information has been received for a case in litigation from information obtained from a published literature article concerning a 4 month old female who on 24-JUN-2002 was vaccinated with a dose of PEDVAXHIB and concomitantly with DTAP and poliovirus vaccine.  Within 24 hours, the patient began to exhibit unusual shaking movements, which proved to be symptoms of a neurological disorder.  The reporter felt that neurological disorder was related to therapy with PEDVAXHIB.  The outcome of the event was not reported.  No further information is available.
Pharyngeal edema; asthenia / fatigue, chest pain, dysphea, fever; injection site erythema, injection site induration, neck pain, otic pain,  Information has been recived from a physician concerning a female patient in her late thirties who in September 2000 was vaccinated IM with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generatin lot #635466 /0782K.  One week later she was vaccinated with pneumococcal vaccine 23 polyvalent PNU -imune 23.  Within 24 hours after vaccination with pneuomococcal vaccine 23 polyvalent (PNU-Imune 23) the patient experienced a swollen throat, shortness of breath, chest tightness (mostly in the lying position).  Injection site redness and induration.  The patient also experienced a fever of 99-100f which has persisted for the past four weeks.  Follow up information indicated that the patient was a 30 year old with a history of recurrent herpes simplex.  It was clarified that the measles virus vaccine live (+) mumps virus vaccine live (+) fubella virus vaccine live sencond generation lot # 635466*0728k was administered on approximately 05 Sep 2000 Im in the left deltoid.  There were no illnesses at the time of vaccination.  The follow up information also stated that one week later, on approximately 12 Sep 2000 the patient received in the left arm pneumococcal vaccine 23 polyvalent MSD which conflicts with the previously reported vaccine, pneumococcal vaccine 23 polyvalent pnu-immune 23.  Twenty four hours after the vaccination with pneumoccal vaccine 23 polyvalent (MSD) the patient experienced a fever of 101F, erythema at the infection site and one week later developed left side neck pain into the left ear.  Approximately 3 week later the patient continued to have a low grade temperature of 99-100f, fatigue shortness of breath, chest tightness, a choking feeling in the throat and increased pain.  The patient was given amithromycin without improvement.  No further information is available.
anxious; dry mouth and feelings of thirst a few hours later. Elevated heart rate; dry mouth and feelings of thirst a few hours later.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 41 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 11:00 (Lot number: EP7534) at the age of 41 years as dose 1, single for covid-19 immunisation, prophylaxis. Relevant medical history included: "postpartum cardiomyopathy", start date: Jan2021 (ongoing); "seasonal allergies" (unspecified if ongoing); "heart rate" (unspecified if ongoing). Concomitant medication(s) included: CARVEDILOL taken for cardiac disorder (ongoing); CLARITIN [CLARITHROMYCIN] taken for seasonal allergy, start date: Mar2021 (ongoing). The following information was reported: DRY MOUTH (non-serious), THIRST (non-serious) all with onset 19Mar2021, outcome "recovered" (21Mar2021) and all described as "dry mouth and feelings of thirst a few hours later."; HEART RATE INCREASED (non-serious) with onset 19Mar2021, outcome "recovering", described as "Elevated heart rate"; ANXIETY (non-serious), outcome "unknown", described as "anxious". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: No prior vaccinations within 4 weeks. No AE(s) following prior vaccination. relevant tests were done.  There is product complaint regarding elevated heart rate while taking carvedilol. : Caller reported the carvedilol was dispensed in a pharmacy bottle and was unable to provide NDC number, lot number, or manufacturer.  No follow-up attempts are possible. No further information is expected.
Soreness in her arm; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm) and DIZZINESS (Dizziness) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included MELOXICAM for Arthritis.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness in her arm) and DIZZINESS (Dizziness). At the time of the report, PAIN IN EXTREMITY (Soreness in her arm) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Report from pt's husband. Pt experienced joint pains (knees, ankles, and elbows) after receiving Fluvirin (for the first time). Pains reported as often quite severe. Pt's husband also experienced adverse event after receiving Fluvirin. Case linked to MPU2000-00086. Follow up above case received from a practice nurse. Pt (female 69 years old, height: 155cm, weight: 62Kg) experienced pains in ankles, knees, shoulders, and wrists (onset three to four weeks), cold sore inside nose and clicking of all joints after receiving (intramuscular dose) of Fluvirin. Pains unresolved. Outcome of other AE's unknown. Medication to treat AE: paracetamol and Ibruprofen spray. X-ray taken of knees and ankles. Medical history of painful spondylosis reported to be ongoing. Pt has not received previous vaccinations for flu. Further info received from the pt's husband stated that the pt continues to suffer acutely with pains in her ankles. She has consulted a rheeumatologist, who prescribed physiotherapy and a course of drugs (details not provided), and considered that the symptoms were consistent with a reaction to the vaccine. The reporter stated that the pain has reduced but has not gone completely, and that catching a cold still brings on the same symptoms. A follow-up report from a health professional was received on 8/19/02. The 69 year old female pt experienced pains in ankles, knees, shoulders, and wrists, clicking joints and had a cold sore in the nose, which was considered to be incapacitating three to four weeks after receiving a Fluvirin vaccine on 10/19/99. The pt received betnovate cream concomitantly. The pt had a medical history of spondylosis. The pt was diagnosed with osteoarthritic change in both knee joints on 2/8/00. The pt had not been given a flu-vaccination before. Pt also treated with oral ibuprofen since November 1999. At the time of reporting it was unknown if the pt had recovered. The reporter has assessed the relation of study medication to the event as probable.
ADMINISTRATION OF VACCINE OUTSIDE EXCURSION REQUIREMENTS; VACCINE OUTSIDE EXCURSION TEMPERATURE 51F FOR 15 HOURS; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1821286 expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced administration of vaccine outside excursion requirements, and vaccine outside excursion temperature 51f for 15 hours. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the administration of vaccine outside excursion requirements and vaccine outside excursion temperature 51f for 15 hours was not reported. This report was non-serious. This report was associated with product quality complaint: 90000184262. The suspected product quality complaint has been confirmed to be voided (no PQC identified) based on the PQC evaluation/investigation performed.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 36 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 36 years as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "didn't feel good after the Covid booster". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.